Cite
HARVARD Citation
Fox, R. et al. (2020). PROMIS® and Neuro-QoLTM measures are valid measures of health-related quality of life among patients with familial chylomicronemia syndrome. Expert review of cardiovascular therapy. pp. 231-238. [Online].